BLANK ROME GOVERNMENT RELATIONS for EMERGENT BIOSOLUTIONS INC.
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Defense DEF
National Defense Authorization Act (NDAA), S. 1790 - provisions related to biological and chemical defense. Department of Defense Appropriations for Medical Countermeasures.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER G ELLISON | — |
| STEPHEN PERANICH | — |
Disaster Planning/Emergencies DIS
FY 2020 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government. Re-authorization of the Pandemic and All-Hazards Preparedness Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHEN PERANICH | — |
Health Issues HCR
Re-authorization of the Pandemic and All-Hazards Preparedness Act. Opioid and heroin addiction legislation. Naloxone access, co-prescribing opioid guidelines.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHEN PERANICH | — |
Budget/Appropriations BUD
FY 2020 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GENEVIEVE COWAN | — |
| JENNIFER G ELLISON | — |
| STEPHEN PERANICH | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.